Woodland Hills, CA, United States of America

Mohssen Fard


Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 114(Granted Patents)


Company Filing History:


Years Active: 2005-2012

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Mohssen Fard: Innovator in Cardiac Rhythm Management

Introduction

Mohssen Fard is a notable inventor based in Woodland Hills, CA (US). He has made significant contributions to the field of cardiac rhythm management, holding a total of 5 patents. His work focuses on innovative solutions for detecting myocardial ischemia, which is crucial for improving patient outcomes in cardiac care.

Latest Patents

One of Mohssen Fard's latest patents involves ischemia detection using intra-cardiac signals. This patent describes an implanted cardiac rhythm management device that is capable of detecting myocardial ischemia by evaluating electrogram features. Specifically, it identifies changes in the electrogram segment during the early part of the ST segment, which is strategically chosen to avoid interference from the T-wave. This innovative approach enhances the accuracy of ischemia detection, providing critical information for timely medical intervention.

Career Highlights

Throughout his career, Mohssen Fard has been associated with Pacesetter, Inc., a company known for its advancements in cardiac devices. His expertise in the field has led to the development of groundbreaking technologies that improve the quality of life for patients with heart conditions. His contributions have been instrumental in advancing the capabilities of cardiac rhythm management devices.

Collaborations

Mohssen Fard has collaborated with several professionals in the field, including Peter Boileau and Jong Gill. These collaborations have fostered an environment of innovation and have contributed to the successful development of new technologies in cardiac care.

Conclusion

In summary, Mohssen Fard is a distinguished inventor whose work in cardiac rhythm management has led to significant advancements in the detection of myocardial ischemia. His patents and collaborations reflect his commitment to improving patient care through innovative technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…